MEMBER OF THE BOARDBarbara Angehrn Pavik
Barbara Angehrn Pavik holds a Master's degree in economics from the University of St. Gallen. She has worked in the international healthcare industry for over 20 years in various management positions, currently as CEO of Asceneuron SA, Lausanne. Prior to that, she held management positions at Vifor Pharma Group, Stepstone Pharma, Exelixis Pharmaceuticals International, Onyx Pharmaceuticals International and Amgen International, among others. Since 2023, she has been a member of the Board of Directors of Bellevue Group.